Ouabain suppresses the growth and migration abilities of glioma U‑87MG cells through inhibiting the Akt/mTOR signaling pathway and downregulating the expression of HIF‑1α

• DOI: 10.3892/mmr.2018.8587
• Publication Date: 2018-02-12T09:59:02Z
• Authors: Xiao‑Sa Yang; Zhong‑Wei Xu; Tai‑Long Yi; Rui‑Cheng Xu; Jie Li; Wen‑Bin Zhang; Sai Zhang; Hong‑Tao Sun; Ze‑Qi Yu; Hao‑Xiang Xu; Yue Tu; Shi‑Xiang Cheng
• Keywords: 0303 health sciences; Cell Survival; TOR Serine-Threonine Kinases; Articles; Glioma; Hypoxia-Inducible Factor 1, alpha Subunit; 3. Good health; Gene Expression Regulation, Neoplastic; 03 medical and health sciences; Cell Movement; Cell Line, Tumor; Humans; Corrigendum; Ouabain; Proto-Oncogene Proteins c-akt; Signal Transduction

Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that several pairings of panels in Fig. 5, as shown on p. 5599, were strikingly similar. After having examined their original data, the authors realized that they uploaded some images incorrectly during the process of compiling this figure, and that there were duplicated data panels in this figure. However, the authors were able to consult their original data, and had access to the correct images. The revised version of Fig. 5, showing the correct data for the Akt/Control, p‑Akt/Control, mTOR/0.05 μM Ouabain, HIF‑1α/0.05 μM Ouabain and Akt/0.5 μM Ouabain experiments, is shown opposite. Note that the replacement of the erroneous data does not affect either the results or the conclusions reported in this paper, and all the authors agree to this Corrigendum. The authors are grateful to the Editor of Molecular Medicine Reports for granting them this opportunity to publish a Corrigendum, and apologize to the readership for any inconvenience caused. [the original article was published in Molecular Medicine Reports 17: 5595‑5600, 2018; DOI: 10.3892/mmr.2018.8587].